Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
November 21, 2022
Are revisions to remdesivir dosing needed for treating SARS-CoV-2?
From the Schiffer lab, Clinical Research and Vaccine and Infectious Disease Divisions
Latest Fred Hutch research on COVID-19
How Hutch scientists have been tackling coronavirus in lab and clinic
Mathematical modeling and phylodynamics of HIV intrahost evolution
From the Schiffer Lab, Vaccine and Infectious Disease Division
What Hutch coronavirus experts are saying about omicron
Some answers, but many questions, about highly mutated new variant of COVID-19 virus
Modeling of human cytomegalovirus infection dynamics in patients
From the Schiffer lab, Vaccine and Infectious Disease Division
Hopes and predictions for 2022
Hutch researchers look ahead to an increase in cancer screening, improved vaccines and greater trust in science
Science Says: Cracking the code in solid tumors
How scientists are developing targeted new therapies for cancers of the breast, lung, stomach and more
Tip Sheet: Disparities in cancer outcomes, catching up on cancer screenings, boosting immunotherapy effectiveness and SARS-CoV-2 origins
Summaries of recent Fred Hutch research findings and other news
Addressing a 'massive unmet need' in COVID-19 treatment
COVID-19 Clinical Research Center tests drugs to reduce severe infections
There’s no crystal ball for modeling the pandemic
Mathematical modelers explain challenges, limitations of their work to predict COVID-19 outcomes
Modeling the kinetics of an HIV cure
From the Schiffer group, Vaccine and Infectious Disease Division
Vaccines stop COVID-19 symptoms, but do they stop transmission?
Researchers mull options, including college dorm studies and 'human challenge' trials, to find answer
Celebrate safely: Scientists offer advice, urge vigilance during holidays
'Now is the time for delayed gratification' — so skip big gatherings and travel to prevent the spread of COVID-19
From the freezers, a speedier way to evaluate antiviral drugs
Lookback research showed today’s ‘viral load’ measurements and machine learning quickly mirrored outcomes of older, slower trials
Imperfect, widely used measures best option against COVID-19, argues Dr. Joshua Schiffer
We need tests, masks, treatments and vaccines to be widespread, not perfect, says infectious disease expert in New York Times editorial
Tip Sheet: Colorectal cancer, COVID-19 super-spreading, gene therapy for herpes, contagious cancer in Tasmanian devils – and more
Summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.
Computer model offers insights on COVID-19 super-spreading
New research compares transmission patterns of SARS-CoV-2 with those of influenza
Fred Hutch and University of Washington experts: Treat COVID-19 earlier to save lives
New review article in Open Forum Infectious Diseases suggests “golden opportunity being missed”
Antiviral cytokines pick up T cell slack
From the Schiffer group, Vaccine and Infectious Disease Division